Document is current
Any future updates will be listed below
-
Authors
Asch, Ruth H. https://orcid.org/0000-0002-9575-0183
Naganawa, Mika
Moisieienko, Karina
Weed, Mia
Kapinos, Michael
Zheng, Ming-Qiang
Hillmer, Ansel T.
Carson, Richard E.
Pietrzak, Robert H.
Esterlis, Irina
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01NS094253)
National Institute of Mental Health (R01AG052560, R01AG065474)
National Center for Advancing Translational Sciences (KL2TR001862)
- License Information
-
More Information
Article History
Received: 14 October 2024
Accepted: 19 January 2025
First Online: 3 February 2025
Declarations
:
: Scanning procedures were approved and overseen by the Yale University Human Investigation Committee and Radiation Safety Committee in accordance with the United States federal policy for the protection of human research subjects. Written informed consent was obtained from all subjects after complete explanation of study procedures and prior to participation.
: Not applicable.
: The authors have no relevant financial interests to disclose. The radioligand 18F-SynVesT-1 is contained in the US patent US1151875482 and R.E.C. is listed as an inventor.
